Extended use of brentuximab vedotin before autologous stem-cell transplantation would benefit refractory systemic anaplastic large-cell lymphoma
2016 ◽
Vol 95
(11)
◽
pp. 1913-1915
◽
2014 ◽
Vol 168
(4)
◽
pp. 557-563
◽
2014 ◽
Vol 12
(3)
◽
pp. 323-326
◽
2006 ◽
Vol 12
(6)
◽
pp. 641-647
◽
2007 ◽
Vol 85
(2)
◽
pp. 105-107
◽
1996 ◽
Vol 134
(4)
◽
pp. 811-813
◽
2001 ◽
Vol 29
(5)
◽
pp. 425-431